Determining blood group antigens by serological methods may be unreliable in certain situations, such as in patients after chronic or massive transfusion. Red cell genotyping offers a complementary approach, but current methods may take much longer than conventional serological typing, limiting their utility in urgent situations. To narrow this gap, we devised a rapid method using direct polymerase chain reaction (PCR) amplification while avoiding the DNA extraction step. DNA was amplified by PCR directly from plasma or serum of blood donors followed by a melting curve analysis in a capillary rapid-cycle PCR assay. We evaluated the single nucleotide polymorphisms underlying the clinically relevant Fy a , Fy b , Jk a and Jk b antigens, with our analysis being completed within 40 min of receiving a plasma or serum sample. The positive predictive value was 100% and the negative predictive value at least 84%. Direct PCR with melting point analysis allowed faster red cell genotyping to predict blood group antigens than any previous molecular method. Our assay may be used as a screening tool with subsequent confirmatory testing, within the limitations of the falsenegative rate. With fast turnaround times, the rapid-cycle PCR assay may eventually be developed and applied to red cell genotyping in the hospital setting.
Summary
Determining blood group antigens by serological methods may be unreliable in certain situations, such as in patients after chronic or massive transfusion. Red cell genotyping offers a complementary approach, but current methods may take much longer than conventional serological typing, limiting their utility in urgent situations. To narrow this gap, we devised a rapid method using direct polymerase chain reaction (PCR) amplification while avoiding the DNA extraction step. DNA was amplified by PCR directly from plasma or serum of blood donors followed by a melting curve analysis in a capillary rapid-cycle PCR assay. We evaluated the single nucleotide polymorphisms underlying the clinically relevant Fy a , Fy b , Jk a and Jk b antigens, with our analysis being completed within 40 min of receiving a plasma or serum sample. The positive predictive value was 100% and the negative predictive value at least 84%. Direct PCR with melting point analysis allowed faster red cell genotyping to predict blood group antigens than any previous molecular method. Our assay may be used as a screening tool with subsequent confirmatory testing, within the limitations of the falsenegative rate. With fast turnaround times, the rapid-cycle PCR assay may eventually be developed and applied to red cell genotyping in the hospital setting.
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Molecular immunohematology methods are increasingly used to determine blood group antigens in routine patient care. Established first line indications for red cell genotyping include prenatal diagnosis, such as the prediction of the fetus' phenotype from the mother's peripheral blood; blood group phenotypes that cannot be discriminated by serology; and blood group typing in recipients of massive or chronic transfusions (Denomme & Flegel, 2008; Wagner, 2010) . Direct polymerase chain reaction (PCR) has been applied to blood donor typing using heat-treated plasma samples without DNA isolation (Silvy et al, 2015) , a simple but not rapid procedure. Direct PCR with inhibitor-resistant polymerases (Trombley Hall et al, 2013) and real-time PCR (Chen et al, 2015) , widely applied in microbiology, has also enabled fast turnaround times, but has not been applied to red cell genotyping so far. Since they were introduced in 1992 (Higuchi et al, 1992 ) and applied to quantitative PCR using dual-labelled fluorogenic probes in 1996 (Heid et al, 1996) , real-time PCR platforms generally offer the fastest turnaround times. Instrumentation for rapid thermocycling in capillary tubes by a stream of hot air was designed in 1989 (Wittwer et al, 1989) and by 1997, this capillary rapid-cycle PCR, when combined with resonance energy transfer probes and fluorescence analysis (Lay & Wittwer, 1997) , enabled allele determination, known as genotyping, in patients. Araujo et al (2001 Araujo et al ( , 2002 were the first to apply capillary rapid-cycle PCR to red cell genotyping. This approach has repeatedly been used for blood group genotyping by Polin and colleagues since 2007 (Polin et al, 2007 (Polin et al, , 2008 (Polin et al, , 2009 .
The original implementation of red cell genotyping required agarose gel electrophoresis (Gassner et al, 1996; Flegel et al, 1998; Prager, 2007) and covered a relevant number of all known alleles at the time (Flegel, 2007) . The first advanced platforms, including BloodGen (Avent et al, 2009 ) and BeadChip (Hashmi et al, 2005) focused on the highly accurate research paper determination of most clinically relevant alleles to limit the rate of incorrect antigen predictions (Flegel, 2007) . While this approach was conceptually critical to foster the adoption of red cell genotyping, it required rather elaborate assays and the acceptance of higher costs and longer turnaround-times. An ideal assay for red cell genotyping would be highly accurate, cheaper than conventional serology and at least as fast.
For many years, the perceived slowness of red cell genotyping impeded its wide implementation (Flegel et al, 2015a) : Most serological antigen determinations are completed within a few minutes to half an hour. These serological results are generally very reliable in donors and patients, if not the recently transfused (Rujirojindakul & Flegel, 2014) . In contrast, current molecular methods (Wagner, 2010) usually take several hours if the time required for DNA isolation and data analysis is properly considered. Often samples have to be transferred to a different laboratory, incurring additional delays until the results become available. In the case of imminent blood need, the results of red cell genotyping are never available when blood units have to be released. Overcoming this gap in turnaround time (Flegel et al, 2015a) may enable the wider use of molecular methods in patients who are known to benefit from red cell genotyping.
Currently the fastest available or published turnaround times, such as the conventional capillary cycling approaches (Polin et al, 2008) and the Flougene platform (Honger et al, 2015) , approximate 90 min after DNA isolation. A turnaround time of 1 h is considered acceptable for red cell genotyping in the case of urgent blood need (Flegel et al, 2015a) .
Possible targets for increasing the turnaround time for PCR assays include the times needed for DNA extraction, PCR thermocycling and post-PCR analysis. We developed a method that eliminated the need for DNA extraction, applied a very rapid thermocycling scheme and enabled PCR product detection in the PCR tubes. Our method combined direct PCR from plasma or serum with melting curve analysis. We issued screening results of red cell genotyping within 40 min of receiving a plasma or serum sample.
Materials and methods

Blood donors
We collected two sets of 100 blood samples at random from routine blood donations in Northern Germany (cohort 1 and 2), collected at different times and representative of Caucasian individuals. Written informed consent for use in research of blood donor samples was obtained from all subjects as part of the routine blood donation procedure.
Blood samples
Whole blood samples were collected, either with EDTA as anticoagulant (plasma for Cohort 1) or without anticoagulation (serum for Cohort 2), and centrifuged at 1140 g for 4 or 5 min to obtain plasma or serum, respectively. No DNA was extracted. Serum was older than 1 day at the time of testing (Lee et al, 2001 ).
DNA amplification with melting point analysis
The assay was completed in one tube. Either plasma or serum was used; we did not make use of any extracted DNA. Our capillary rapid-cycle PCR was an adaption of previously used methods (Polin et al, 2008) with the thermocycling conditions pushed to an extreme short time limit. We added 1 ll of serum or plasma to 9 ll of a master mix. The final volume of 10 ll contained 5 ll of PCR mix (Finnzyme Phusion Blood Direct PCR kit; Biozym, Hessisch-Oldendorf, Germany), 4 ll of a solution of primer and probe oligonucleotides (Table I) and 1 ll of sample. Where necessary, we designed longer PCR primers allowing higher annealing temperatures (Table I) , thus reducing the time lapse for cooling to reach the required annealing temperature. The total reaction mixture was transferred to a glass capillary (Light cycler capillaries 20 ll; Roche Diagnostics, Mannheim, Germany). The DNA amplification started at 98°C for 60 s; followed by 50 rounds of thermocycling, each consisting of 98°C for 0 s (no hold time), 63°C for 2 s, and 72°C for 8 s, finishing with 98°C for 30 s. The temperature controlled by the instrument (LightCycler 1.2; Roche Diagnostics) indicates the actual air temperature around the glass capillaries adjusted to induce the, somewhat lower, actual reaction temperature of the PCR in the capillaries, selected by the operator for thermocycling (Fig 1) .
Melting curve analysis was performed between 45 and 80°C with a temperature increment of 0Á1°C/s. The melting curves were sketched using the instrument's data analysis software (Light cycler software, version 3.5; Roche Diagnostics) and evaluated visually (Fig 2) . Total time of the procedure was clocked from the first pipetting step touching the plasma or serum until the melting curve analysis was interpreted and the results released by the operator.
Serological typing
The Fy a , Fy b , Jk a , and Jk b antigens were typed by routine serology with licensed polyclonal antisera (Biolith, Hannoversch-M€ unden, Germany).
Resolution of discordant results
Indeterminate and discrepant results were evaluated by repeat testing, which confirmed the molecular and serological results. The discrepant results in 2 donor samples were resolved by additional molecular testing (RBC-Ready Gene KKD; Inno-train, Kronberg, Germany) by using PCR-single specific primer (SSP) for the FY (also termed ACKR1, DARC) gene including the FY x allele (Gassner et al, 2000) .
Hence, there was no need to employ alternate sources of antisera to exclude serological variants. 
Statistics
We determined the value of the genotyping result to predict the serological typing. The positive predictive value (PPV) was calculated by the sum of the true positive (positive in both serological and molecular methods) divided by the sum of the true positive and false positive cases (positive molecular result but negative serological result); the negative predictive value (NPV) was calculated accordingly (Gilchrist, 2009) .
Results
To enable a fast turnaround time, we developed a direct PCR with melting curve analysis in glass capillaries using plasma or serum without DNA isolation.
Rapid-cycle PCR
The thermocycling times of our assay were minimized compared to thermocycling with standard temperature profiles, such that 50 cycles were completed in less than 23 min for three samples (Fig 1, upper panel) . Immediately following the thermocycling, the tube was cooled to 45°C. Then, the temperature was steadily increased by 0Á1°C/s from 45 to 80°C; this melting curve analysis was completed in less than 7 min. The fluorescence detected during the DNA amplification is a function of the cycle number (Fig 1, lower panel) . The whole process of direct PCR with melting curve analysis in glass capillaries was finished within 30 min for three samples (Fig 1) .
Melting curve analysis
The absolute fluorescence, detected during the melting process, was used to calculate the fluorescence change (dF/dT) as a function of the temperature (Fig 2) . The melting curve analysis (Fig 2, upper panels) showed a rapid decrease of fluorescence occurring at 63°C in carriers of FY*B alleles (69°C for FY*A, 63°C for JK*B [also termed SLC14A1*B], 66°C for JK*A). The position of the peak is consistent among all samples. Even in FY heterozygous samples, the peaks for FY*A and FY*B, being separated by 6°C, can unambiguously be distinguished (Fig 2, lower left panel) . For JK homozygous samples, the peaks for JK*A and JK*B, being separated by 3°C only, overlapped considerably (Fig 2, lower right panel) , which caused a broad peak at 64°C for JK heterozygous samples.
Turnaround time
Total time for the analysis was determined from the first pipetting step to the final interpretation of the melting point analysis, when the results were released (Table II) . This time depended on the numbers of samples but was less than 45 min for up to 10 samples. The major time block was thermocycling and melting curve analysis, with approximately 9 min represented by hands-on time including administrative work.
Red cell genotyping
We tested 100 plasma samples in a blinded fashion and obtained the serological results only after red cell genotyping had been completed (Table III) . For the two major antigens in the FY and JK blood group systems, the concordance of molecular and serological results was great; in only two samples the presence of one Fy a and one Jk a antigen was missed, respectively. When our direct PCR assay was applied to serum samples from an independent cohort of 100 random donors, the results were comparable (Table IV) ; the assay was indeterminate or missed the presence of one antigen in six samples.
PPV and NPV
The PPVs were 100% for Fy a , Fy b, Jk a and Jk b antigens in plasma and serum (Table V) . With one exception, the NPVs were well above 90%; our rapid-cycle PCR assay seemed to perform better with plasma than serum.
Discussion
We developed an assay for red cell genotyping of the major FY and JK antigens with a rapid turnaround time. The assay was completed within 40 min from receiving a plasma or serum sample. This screening assay may be useful in clinical settings requiring FY and JK antigen information, while definitive red cell genotyping is pending. Our assay utilized a DNA polymerase mix that allowed direct amplification from plasma or serum in conjunction with rapid thermocycling and melting curve analysis. The optimal assays suited for distinct clinical applications may differ, because high accuracy, low cost and fast turnaround times are often mutually exclusive and unlikely to be featured by a single assay. Highly accurate platforms are the best fit for red cell genotyping of patients in elective situations; they can be licensed as tests of record but tend to be elaborate and low throughput (Hashmi et al, 2005; Avent et al, 2009 ). For mass scale donor typing, the largest datasets were established using methods optimized for low cost and high throughput screening, correcting for inaccuracies by targeted serological checks (Perreault et al, 2009; Wagner, 2010; Flegel et al, 2015b) . For patients with urgent transfusion needs, we reasoned that the decisive feature was turnaround time (Flegel et al, 2015a) . The current study demonstrated a turnaround time that compared favourably with that of standard serology, particularly if serological typing is difficult to perform following multiple transfusions.
Conventional PCR assays typically require DNA isolation. The various commercial DNA extractions methods (Tan & Yiap, 2009 ) take between 15 min and 1 h before isolated genomic DNA becomes available. Simplified DNA isolation methods allowed us to save time and cost (Wagner et al, 2008) . The logical next step was bypassing DNA isolation altogether by using DNA polymerase mixes enabling direct amplification from blood. This approach has been established for some conventional agarose-based PCR (Awad & El-Tarras, 2011; Fuehrer et al, 2011) and in infectious disease testing (Fuehrer et al, 2011; Taylor et al, 2011) . Direct PCR from unprocessed whole blood had also been combined with a rapid detection method by Manage et al (2010) utilizing a special microfluidic device. The discrimination of alleles remained a challenge in the presence of haemoglobin. Hence, we switched to using plasma and serum as the source of DNA.
DNA analysis in the plasma of a pregnant mother is routine for determining the fetal genotype (Scheffer et al, 2011; Doescher et al, 2013) . Even during pregnancy the majority of the DNA in plasma represents the mother's genotype and only up to 10% derives from the fetus (Bauer et al, 2006) . Hence, plasma should be an acceptable source for patient red cell genotyping. Our assay, with amplicons of less than 170 bp, adjusted well to the highly fragmented DNA found in plasma (Chan et al, 2004) . Serum may be an even more efficient source of human DNA as the DNA concentration in serum may greatly increase over its concentration in plasma after several days of storage (Lee et al, 2001) as nucleated cells release their DNA while disintegrating during clotting and storage. Serum also contains fewer components that could interfere with PCR. We evaluated both plasma (Table III) and serum (Table IV) as sources for DNA. Our results, however, did not suggest improved accuracy when using serum. In an urgent situation, plasma may be slightly faster to obtain and better defined than serum because the clotting process can intentionally be disregarded. Neither serum nor plasma has been widely applied for red cell genotyping in patients. Although, reliability after massive plasma transfusion, in pregnant patients and in aplastic patients is yet to be established, clinical experiences with red cell genotyping are generally very promising (Rujirojindakul & Flegel, 2014) . The false-negative results (Tables III and IV) may be explained by the small sample input of 1 ll plasma or serum, fairly devoid of nucleated cells. The low DNA concentration, representing a few gene copies per test tube, may impose a bottleneck, as observed before in nano-volume assays (Flegel et al, 2015b) . The current NPV (Table V) precluded use of our assay as a test of record. It may be utilized in clinical situations when a result is rapidly needed for a patient. False-negative results have limited impact, because they will lead to an overly conservative transfusion strategy rather than cause harm to any patient.
Our thermocycling instrument was limited to the detection of 2 colours, not allowing us to multiplex more than 2 reactions at this time. For our proof of principle, we chose the 2 main polymorphisms of the FY and JK blood group systems. These antigens are clinically important and often difficult to determine after recent transfusions (Rujirojindakul & Flegel, 2014) or in the presence of a strongly positive direct agglutination test (Reid, 2007) . Additional alleles, such as FY*02N.01 (Storry et al, 2014 ) with a GATA box mutation (Tournamille et al, 1995; Schmid et al, 2012) should be added in the future along with other clinically relevant blood group systems. While we do not expect limitations by moving the technique to newer platforms that allow multiplexing of 4 or more reactions in a single capillary or tube, adaption to each new platform has to be carefully evaluated. The first increase in fluorescence occurred at cycles 30-32 and all positive samples yielded positive signals at cycle 40 (Fig 1) . Hence, fewer than 50 cycles may suffice, decreasing the thermocycling time to less than 22 min (Table II) . Our assay is a promising novel approach. We adapted an almost 20-year-old technique, hybridization probes in conjunction with rapid-cycle PCR. Elimination of a DNA extraction step further shortened the time to result and also much reduced the hands-on time (Table II) . Red cell genotyping was thus accomplished within 40 min, a turnaround time generally accepted in case of urgent blood need (Flegel et al, 2015a) . In addition, because the assay required only 2 pipetting steps, it was mostly walk-away, and could be developed for automatic visual interpretation, making molecular analysis easier to integrate into the routine serological workflow. Further development may eventually facilitate red cell genotyping with fast turnaround times in routine hospital settings.
